Looking back to an incredible week at European Practitioners Symposium on Equine Reproduction (ESER 2026) in Bruges, Belgium. Bringing together more than 500 equine reproduction professionals from over 30 countries, the event once again demonstrated the strength of a global veterinary community and our shared commitment to advancing reproductive medicine.
Under the theme“Focus on Fertility: Diagnostic Tests and Therapeutic Protocols in Mares and Stallions”, delegates explored the latest evidence, clinical protocols, and practical approaches to improving fertility management in both mares and stallions. Key topics included endometritis, ovarian pathology, embryonic loss, embryo transfer, assisted reproductive technologies (ART), semen evaluation, cryopreservation, sex-sorting, and stallion management.
One of the highlights for us was announcing that, from 2027, BotuFlush OPU and BotuOocyte, will become part of our product portfolio and be available in Europe. BotuFlush OPU is specifically designed to support ovum pick-up (OPU) procedures by helping prevent oocytes from adhering to tubing, filters, and dishes, while also providing anticoagulant support through heparin to reduce clotting during OPU procedures. These additions further strengthen our reproductive medicine offering and reflect our commitment to bringing advanced, field-proven technologies to equine reproduction specialists.
We were also delighted to have Daniel from Botupharma joining us at our booth throughout the congress.
A sincere thank you to all speakers, sponsors, organizers, and participants who made ESER 2026 such a memorable and impactful meeting. We leave inspired by the innovations shared, the collaborations formed, and the exciting future of equine reproductive medicine.
Looking forward to ESER 2028!